CJC-1295 With DAC
GHRH analog with drug-affinity complex studied for extended-duration growth-hormone pulse research.
Vial concentration
CJC-1295 With DAC
5 mgThis is a clinician-reviewed research peptide. Pricing is provided as part of an approved, personalized plan after your assessment is reviewed.
Not sure where to start?
Discover what may fit your goals — a short, personalized Regenexa Assessment.
Take Your Assessment →- 🔒 Secure & encrypted checkout
- 📦 Fast, discreet worldwide shipping
- 🧪 Pharmaceutical-grade quality
- 🔬 Research use only
GHRH(1-29) analog conjugated to a drug-affinity complex that binds serum albumin, extending its half-life dramatically versus native GHRH or no-DAC variants — supports less-frequent dosing at the cost of less-pulsatile GH release.
Receptors
Half-life: Approximately 6–8 days, due to the albumin-binding drug-affinity complex.
Ask Regenexa AI about CJC-1295 With DAC
Get plain-language answers on mechanism, evidence and how it compares to other peptides — grounded in Regenexa's verified data.
“What does "DAC" mean and why does it matter?”Ask Regenexa AI →
CJC no-DAC / Ipamorelin
Tesamorelin
IGF-1 LR3
Ipamorelin